Lumos Pharma (LUMO) Stock Chart & Stock Price History → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free LUMO Stock Alerts $2.86 -0.04 (-1.38%) (As of 05/13/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lumos Pharma Stock Price Performance5 Day Performance-5.30%1 Month Performance+8.33%3 Month Performance-6.23%6 Month Performance-8.92%Year-To-Date Performance-10.06%1 Year Performance-15.51% Receive LUMO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceHow to Make 100X on the AI BoomFor over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs LUMO Stock Chart for Tuesday, May, 14, 2024 LUMO Chart by TradingView Lumos Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$2.90$2.86-1.38%$2.93$2.7610,964 shs$23.22 million05/10/2024$3.02$2.92-3.31%$3.05$2.7332,788 shs$23.71 million05/09/2024$3.00$3.02+0.67%$3.19$2.9931,235 shs$24.52 million05/08/2024$3.02$3.00-0.66%$3.03$2.9612,524 shs$24.36 million05/07/2024$3.00$3.02+0.67%$3.07$2.9226,477 shs$24.52 million05/06/2024$2.96$3.00+1.35%$3.05$2.9142,163 shs$24.35 million Get the Latest News and Ratings for LUMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$3.04$2.96-2.63%$3.05$2.9069,636 shs$24.04 million05/02/2024$3.02$3.04+0.66%$3.06$2.98125,196 shs$24.69 million05/01/2024$2.87$3.02+5.23%$3.07$2.73270,583 shs$24.51 million04/30/2024$2.89$2.87-0.69%$2.90$2.7019,517 shs$23.30 million04/29/2024$2.77$2.89+4.33%$2.92$2.7713,699 shs$23.47 million04/26/2024$2.76$2.83+2.36%$2.83$2.74688 shs$22.94 million04/25/2024$2.82$2.76-2.13%$2.81$2.711,569 shs$22.41 million04/24/2024$2.80$2.82+0.71%$2.93$2.7246,348 shs$22.90 million04/23/2024$2.68$2.80+4.48%$2.85$2.7017,078 shs$22.74 million04/22/2024$2.59$2.68+3.47%$2.69$2.604,650 shs$21.75 million04/19/2024$2.62$2.59-1.15%$2.83$2.5312,311 shs$21.03 million04/18/2024$2.46$2.62+6.50%$2.76$2.4112,386 shs$21.27 million04/17/2024$2.52$2.46-2.38%$2.53$2.4114,403 shs$19.97 million04/16/2024$2.45$2.52+2.86%$2.69$2.4618,763 shs$20.44 million04/15/2024$2.64$2.45-7.20%$2.57$2.4128,356 shs$19.87 million04/12/2024$2.71$2.55-5.90%$2.73$2.4115,352 shs$20.68 million04/11/2024$2.69$2.71+0.74%$2.90$2.6923,100 shs$21.98 million04/10/2024$2.69$2.69$2.69$2.69582 shs$21.82 million04/09/2024$2.65$2.69+1.51%$2.77$2.654,262 shs$21.82 million04/08/2024$2.74$2.65-3.28%$2.84$2.659,114 shs$21.49 million04/05/2024$2.78$2.77-0.36%$2.81$2.732,550 shs$22.47 million04/04/2024$2.76$2.78+0.72%$2.84$2.6012,271 shs$22.55 million04/03/2024$2.84$2.76-2.82%$2.85$2.766,882 shs$22.38 million04/02/2024$2.86$2.84-0.70%$2.84$2.753,462 shs$23.03 million04/01/2024$2.82$2.86+1.42%$2.90$2.804,523 shs$23.20 million03/29/2024$2.82$2.82$2.94$2.828,854 shs$22.87 million03/28/2024$2.82$2.82$2.94$2.828,854 shs$22.87 million03/27/2024$2.86$2.82-1.40%$2.95$2.816,500 shs$22.87 million03/26/2024$2.79$2.86+2.51%$2.90$2.7718,110 shs$23.20 million03/25/2024$2.78$2.79+0.36%$2.85$2.756,857 shs$22.63 million03/22/2024$2.90$2.78-4.14%$2.86$2.7112,721 shs$22.55 million03/21/2024$2.89$2.90+0.35%$2.94$2.7520,544 shs$23.52 million03/20/2024$2.73$2.89+5.86%$2.93$2.6021,508 shs$23.44 million03/19/2024$2.66$2.73+2.63%$2.81$2.6517,662 shs$22.14 millionAmerica’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now.03/18/2024$2.70$2.66-1.48%$2.84$2.6413,181 shs$21.57 million03/15/2024$2.66$2.70+1.50%$2.80$2.6533,735 shs$21.90 million03/14/2024$2.97$2.66-10.44%$3.03$2.5156,451 shs$21.57 million03/13/2024$3.02$2.97-1.66%$3.04$2.976,657 shs$24.08 million03/12/2024$3.05$3.02-0.98%$3.08$3.0235,901 shs$24.49 million03/11/2024$3.04$3.05+0.33%$3.05$2.9737,379 shs$24.74 million03/08/2024$3.03$3.04+0.33%$3.10$2.97133,300 shs$24.05 million03/07/2024$3.02$3.03+0.33%$3.05$2.985,915 shs$23.97 million03/06/2024$3.05$3.02-0.98%$3.05$2.9710,927 shs$23.89 million03/05/2024$3.01$3.05+1.33%$3.12$3.0070,149 shs$24.13 million03/04/2024$3.00$3.01+0.33%$3.05$3.008,833 shs$23.81 million03/01/2024$3.05$3.00-1.64%$3.05$2.9311,377 shs$23.73 million02/29/2024$3.05$3.05$3.05$2.917,158 shs$24.13 million02/28/2024$3.04$3.05+0.33%$3.05$2.9520,045 shs$24.13 million02/27/2024$2.99$3.04+1.84%$3.05$3.0330,681 shs$24.05 million02/26/2024$3.00$2.99-0.50%$3.05$2.8253,869 shs$23.61 million02/23/2024$3.02$2.94-2.65%$3.03$2.897,999 shs$23.26 million02/22/2024$2.96$3.02+2.20%$3.03$2.917,194 shs$23.89 million02/21/2024$3.04$2.96-2.80%$3.00$2.965,581 shs$23.37 million02/20/2024$2.96$3.04+2.70%$3.05$2.9218,597 shs$24.05 million02/19/2024$2.96$2.96$3.06$2.9120,000 shs$23.41 million02/16/2024$3.05$2.96-2.95%$3.06$2.9120,028 shs$23.41 million02/15/2024$3.05$3.05$3.12$3.0123,008 shs$24.13 million02/14/2024$3.04$3.05+0.33%$3.10$2.989,921 shs$24.13 million02/13/2024$3.15$3.04-3.49%$3.23$2.997,376 shs$24.05 million Related Companies: Qilian International Holding Group Stock Chart Oncternal Therapeutics Stock Chart Iterum Therapeutics Stock Chart Forte Biosciences Stock Chart Lisata Therapeutics Stock Chart TherapeuticsMD Stock Chart Bullfrog AI Stock Chart Biora Therapeutics Stock Chart CytoMed Therapeutics Stock Chart Cumberland Pharmaceuticals Stock Chart Receive LUMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LUMO) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe only AI company you should be looking atBehind the MarketsCharles Payne Demystifies OptionsUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lumos Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.